Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ONCASPAR safely and effectively. See full prescribing information for ONCASPAR. ONCASPAR (pegaspargase) injection, for intramuscular or intravenous use Initial U.S. Approval: 1994
Medication labelWhy this: Advisory · dailymed-prescription
ONCASPAR® is indicated as a component of a multi-agent chemotherapeutic regimen for the first-line treatment of pediatric and adult patients with ALL. ONCASPAR is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with ALL and hypersensitivity to native forms of L-asparaginase.
- generic_name
- pegaspargase
- product_names
- Pegaspargase
- ndc
- 72694-954, 72694-954-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en